EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Electrochemotherapy and Calcium Electroporation on Hepatocellular Carcinoma Cells: An In-Vitro Investigation

K H K Lindelauf, M Baragona, T Lemainque, R T H Maessen, A Ritter

CardioVascular and Interventional Radiology · 2024-10 · 47 (10) · 1384-1391

DOI: 10.1007/s00270-024-03847-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CardioVascular and Interventional Radiology, online erschienen am 03.09.2024. Verfasst von K H K Lindelauf und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic and Interventional Radiology, University Hospital RWTH Aachen, Aachen, Germany. klindelauf@ukaachen.de. Hauptthemen laut MEDLINE: Electrochemotherapy, Bleomycin, Cisplatin, Electroporation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: H2020 Marie Skłodowska-Curie Actions, Universitätsklinikum RWTH Aachen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Electrochemotherapy, clinically established for treating (sub)cutaneous tumors, has been standardized in the framework of the European Standard Operating Procedure on Electrochemotherapy (ESOPE). Due to common side effects of chemotherapeutic drugs, recent advances focus on non-cytotoxic agents, like calcium, to induce cell death (calcium electroporation). Therefore, this study aims to determine the efficacy of electrochemotherapy with bleomycin or cisplatin, or calcium electroporation on human hepatocellular carcinoma cells (HepG2) in vitro using the ESOPE protocol.

Methods

HepG2 cell viability was measured with a MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay after electrochemotherapy with the chemotherapeutic drugs bleomycin or cisplatin (0–20 µM), or after calcium electroporation (0–20 mM), to determine its efficacy on HepG2 cells in vitro using the ESOPE protocol (8 rectangular pulses, 1000 V/cm, 100 µs) compared to non-electroporated drug treatment.

Results

Cell viability was significantly lower in electroporated samples, compared to their non-electroporated controls (27–75% difference). Electrochemotherapy with bleomycin and calcium electroporation, reached (almost) complete cell death (− 1 ± 3% and 2.5 ± 2%), in the lowest concentration of 2.5 µM and 2.5 mM, respectively. Electrochemotherapy with 2.5 µM cisplatin, significantly decreased cell viability to only 68% (± 7%).

Conclusion

Electrochemotherapy with bleomycin or cisplatin, or calcium electroporation were more effective in reducing the HepG2 cell viability in vitro using the ESOPE protocol compared to the non-electroporated drug treatments alone. When comparing electrochemotherapy, HepG2 cells are more sensitive to bleomycin than cisplatin, in similar concentrations. Calcium electroporation has the same effectiveness as electrochemotherapy with bleomycin, but calcium potentially has a better safety profile and several treatment advantages. Graphical Abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ElectrochemotherapyBleomycinCisplatinElectroporationCarcinoma, HepatocellularLiver NeoplasmsCell SurvivalCalciumHumansHep G2 CellsAntineoplastic AgentsIn Vitro Techniques

Stichwörter der Autor:innen

Calcium electroporationESOPEElectrochemotherapyHepG2Hepatic cancerIn vitro

Substanzen

BleomycinCisplatinCalciumAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Diagnostic and Interventional Radiology, University Hospital RWTH Aachen, Aachen, Germany. klindelauf@ukaachen.de.
  • Philips Research, Eindhoven, The Netherlands. klindelauf@ukaachen.de.
  • Philips Research, Eindhoven, The Netherlands.
  • Department of Diagnostic and Interventional Radiology, University Hospital RWTH Aachen, Aachen, Germany.

Förderung

  • H2020 Marie Skłodowska-Curie Actions
  • Universitätsklinikum RWTH Aachen

Zitieren

APA

Lindelauf, K. H. K., Baragona, M., Lemainque, T., Maessen, R. T. H., & Ritter, A. (2024). Electrochemotherapy and Calcium Electroporation on Hepatocellular Carcinoma Cells: An In-Vitro Investigation. CardioVascular and Interventional Radiology, 47(10), 1384-1391. https://doi.org/10.1007/s00270-024-03847-1

Vancouver

Lindelauf KHK, Baragona M, Lemainque T, Maessen RTH, Ritter A. Electrochemotherapy and Calcium Electroporation on Hepatocellular Carcinoma Cells: An In-Vitro Investigation. CardioVascular and Interventional Radiology. 2024;47(10):1384-1391. doi:10.1007/s00270-024-03847-1

BibTeX
@article{Lindelauf2024,
  author = {Lindelauf, K H K and Baragona, M and Lemainque, T and Maessen, R T H and Ritter, A},
  title = {Electrochemotherapy and Calcium Electroporation on Hepatocellular Carcinoma Cells: An In-Vitro Investigation},
  journal = {CardioVascular and Interventional Radiology},
  year = {2024},
  volume = {47},
  number = {10},
  pages = {1384--1391},
  doi = {10.1007/s00270-024-03847-1}
}
Kostenlos starten →